Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial
Year: 2024
Type: article
Study design: Clinical Trial
Source: The Lancet Infectious Diseases
Authors: Avika Dixit, Richard Bennett, Kashif Ali, Carl Griffin, Robert A Clifford, Mark Turner, Rosanne Poston, Kelly Hautzinger, Anne Yeakey, Bethany Girard, Wen Zhou, Weiping Deng, Honghong Zhou, Sabine Schnyder Ghamloush, Barbara J Kuter, Karen Slobod, Jacqueline M Miller, Frances Priddy, Rituparna Das, Kashif Ali, Madhavi Ampajwala, Andrew Atz, Richard Bennett, Gary Berman, Robert Clifford, Michael Dunn, Frank Eder, George Fuchs, Carl Griffin, John M. Hernandez, Robert Jeanfreau, Kimball Johnson, William Lavery, Jay Meyer, William Muller, Richard Ohnmacht, Amruta Padhye, Khozema Palanpurwala, Carina Rodrigue, Mark Turner, Todd Vasko, John Waits, Peter Warfield
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4392970464